Blockchain Registration Transaction Record

Clene Presents Clinical Data Showing Significant Repair and Remyelination in Neurodegenerative Diseases

Clene presents clinical data at the 2024 AAN Annual Meeting, demonstrating significant repair and remyelination in neurodegenerative diseases. This represents a major advancement in the treatment of ALS and MS, offering hope to patients and investors.

This news represents a major step forward in the treatment of neurodegenerative diseases such as ALS and MS, offering hope to patients and potential investors. The clinical data presented at the AAN Annual Meeting demonstrates the effectiveness of long-term CNM-Au8 treatment in repairing and remyelinating nerve cells, with far-reaching implications for the medical and pharmaceutical industries.